Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03057028 · ClinicalTrials.gov registry record · Phase 1
Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension
A Phase 1 study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT03057028: Completed Phase 1 study, sponsored by Virginia Commonwealth University.
NCT03057028 is a Phase 1 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 7 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03057028, a Phase 1 study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
Pulmonary arterial hypertension (PAH) can result in right ventricular failure and death. Anakinra has been used in patients with left sided heart failure, and the present study looks to determine if anakinra is safe and effective in patients with PAH. To accomplish this goal, we plan to evaluate for exercise improvement (as assessed by cardiopulmonary exercise testing) in 10 patients with PAH on anakinra.
Interventions
- DRUG Anakinra
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-06-07 |
| Phase | Phase 1 |
What the finished NCT03057028 record still lists
NCT03057028 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which Anakinra is the first listed.
NCT03057028 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03057028 about?
NCT03057028 is a clinical study titled "Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension". Pulmonary arterial hypertension (PAH) can result in right ventricular failure and death. Anakinra has been used in patients with left sided heart failure, and the present study looks to determine if anakinra is safe and effective in patients with PAH. To accomplish this goal, we plan to evaluate for...
What is the current status of trial NCT03057028?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2016-04. Estimated completion is 2018-06-07.
What interventions are being tested in trial NCT03057028?
The interventions under investigation include: Anakinra (DRUG).
Who is sponsoring clinical trial NCT03057028?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03057028's enrollment target sits among peer trials
7 1972nd of 2000 higher than 27 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia